| |
Latest 10 SEC filings (by transaction date) for ATXI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Fortress Biotech, Inc. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 413,507 | |
Jan 3/24 | Jan 2/24 | Fortress Biotech, Inc. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 2,101,496 | |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -20,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -128,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -126,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -61,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -18,000 | $0.150 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Direct Ownership | Common Stock | S - Open market or private sale | -264,000 | $0.140 |
Nov 28/23 | Nov 28/23 | Davidow Robert L | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Nov 28/23 | Nov 28/23 | Davidow Robert L | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ATXI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 17/24 | Apr 16/24 | Fortress Biotech, Inc. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 413,507 | |
Jan 3/24 | Jan 2/24 | Fortress Biotech, Inc. | Direct Ownership | COMMON STOCK, PAR VALUE $0.0001 | A - Grant, award or other under Rule 16b-3(d) | 2,101,496 | |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -20,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -128,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -126,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -61,000 | $0.140 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Indirect Ownership | Common Stock | S - Open market or private sale | -18,000 | $0.150 |
Dec 13/23 | Dec 11/23 | Davidow Robert L | Direct Ownership | Common Stock | S - Open market or private sale | -264,000 | $0.140 |
Nov 28/23 | Nov 28/23 | Davidow Robert L | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Nov 28/23 | Nov 28/23 | Davidow Robert L | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |